Meyer Handelman Company’s Standard BioTools LAB Stock Holding History

Meyer Handelman Company’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-17,500	Closed	-$47.4K	–	208
2024 Q1	$47.4K	Hold	17,500	–	–	﹤0.01%	203
2023 Q4	$38.7K	Hold	17,500	–	–	﹤0.01%	190
2023 Q3	$50.8K	Hold	17,500	–	–	﹤0.01%	190
2023 Q2	$33.8K	Hold	17,500	–	–	﹤0.01%	188
2023 Q1	$34.1K	Hold	17,500	–	–	﹤0.01%	185
2022 Q4	$20.5K	Hold	17,500	–	–	﹤0.01%	189
2022 Q3	$19K	Hold	17,500	–	–	﹤0.01%	188
2022 Q2	$28K	Hold	17,500	–	–	﹤0.01%	188
2022 Q1	$63K	Hold	17,500	–	–	﹤0.01%	189
2021 Q4	$69K	Hold	17,500	–	–	﹤0.01%	190
2021 Q3	$115K	Hold	17,500	–	–	﹤0.01%	199
2021 Q2	$108K	Hold	17,500	–	–	﹤0.01%	203
2021 Q1	$79K	Hold	17,500	–	–	﹤0.01%	200
2020 Q4	$105K	Hold	17,500	–	–	﹤0.01%	188
2020 Q3	$130K	Buy	+17,500	New	+$121K	0.01%	180

Other funds holding LAB

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

Meyer Handelman Company's LAB Position: Q2 2024 in Review

Meyer Handelman Company sold out of Standard BioTools (LAB) in Q2 2024, closing a stake of 17,500 shares — an estimated $47.4K sold.

Meyer Handelman Company first reported a position in LAB in Q3 2020 and held it in 15 quarters. The position peaked at $130K in Q3 2020. 144 funds tracked by Wall St. Rank hold LAB as of Q2 2024.

Meyer Handelman Company reported no remaining Standard BioTools position as of Q2 2024 after selling out during the quarter.
Meyer Handelman Company sold 17,500 Standard BioTools shares in Q2 2024, an estimated $47.4K.
Meyer Handelman Company first reported a position in Standard BioTools in Q3 2020 and held it in 15 quarters.
Meyer Handelman Company's Standard BioTools position peaked at $130K in Q3 2020.
144 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2024.

Based on Meyer Handelman Company's 13F filing for Q2 2024, filed 16 Jul 2024.